[HTML][HTML] Doxorubicin-induced cardiotoxicity: An update on the molecular mechanism and novel therapeutic strategies for effective management
Doxorubicin (Dox) is a secondary metabolite of the mutated strain of Streptomyces peucetius
var. Caesius and belongs to the anthracyclines family. The anti-cancer activity of Dox is …
var. Caesius and belongs to the anthracyclines family. The anti-cancer activity of Dox is …
A systematic review of the protective effects of silymarin/silibinin against doxorubicin-induced cardiotoxicity
M Singh, MM Kadhim, A Turki Jalil, SK Oudah… - Cancer Cell …, 2023 - Springer
Purpose Although doxorubicin chemotherapy is commonly applied for treating different
malignant tumors, cardiotoxicity induced by this chemotherapeutic agent restricts its clinical …
malignant tumors, cardiotoxicity induced by this chemotherapeutic agent restricts its clinical …
Glutathione system enhancement for cardiac protection: pharmacological options against oxidative stress and ferroptosis
M Tan, Y Yin, X Ma, J Zhang, W Pan, M Tan… - Cell Death & …, 2023 - nature.com
The glutathione (GSH) system is considered to be one of the most powerful endogenous
antioxidant systems in the cardiovascular system due to its key contribution to detoxifying …
antioxidant systems in the cardiovascular system due to its key contribution to detoxifying …
[HTML][HTML] Doxorubicin-induced cardiomyopathy: from molecular mechanisms to therapeutic strategies
Y Octavia, CG Tocchetti, KL Gabrielson… - Journal of molecular and …, 2012 - Elsevier
The utility of anthracycline antineoplastic agents in the clinic is compromised by the risk of
cardiotoxicity. It has been calculated that approximately 10% of patients treated with …
cardiotoxicity. It has been calculated that approximately 10% of patients treated with …
Loss of TRIM21 alleviates cardiotoxicity by suppressing ferroptosis induced by the chemotherapeutic agent doxorubicin
Background Doxorubicin, an anthracycline chemotherapeutic agent, is widely used in the
treatment of many cancers. However, doxorubicin posts a great risk of adverse …
treatment of many cancers. However, doxorubicin posts a great risk of adverse …
Resveratrol and cancer: focus on in vivo evidence
LG Carter, JA D'Orazio… - Endocrine-related …, 2014 - erc.bioscientifica.com
Resveratrol is a naturally occurring polyphenol that provides a number of anti-aging health
benefits including improved metabolism, cardioprotection, and cancer prevention. Much of …
benefits including improved metabolism, cardioprotection, and cancer prevention. Much of …
[HTML][HTML] Preclinical and clinical evidence for the role of resveratrol in the treatment of cardiovascular diseases
BNM Zordoky, IM Robertson, JRB Dyck - Biochimica et Biophysica Acta …, 2015 - Elsevier
Cardiovascular disease is the leading cause of death worldwide. Despite advancements in
diagnosis and treatment of cardiovascular disease, the incidence of cardiovascular disease …
diagnosis and treatment of cardiovascular disease, the incidence of cardiovascular disease …
Cardiotoxicity of anticancer drugs: the need for cardio-oncology and cardio-oncological prevention
A Albini, G Pennesi, F Donatelli… - Journal of the …, 2010 - academic.oup.com
Due to the aging of the populations of developed countries and a common occurrence of risk
factors, it is increasingly probable that a patient may have both cancer and cardiovascular …
factors, it is increasingly probable that a patient may have both cancer and cardiovascular …
Resveratrol for breast cancer prevention and therapy: Preclinical evidence and molecular mechanisms
D Sinha, N Sarkar, J Biswas, A Bishayee - Seminars in cancer biology, 2016 - Elsevier
Globally, breast cancer is the most frequently diagnosed cancer among women. The major
unresolved problems with metastatic breast cancer is recurrence after receiving objective …
unresolved problems with metastatic breast cancer is recurrence after receiving objective …
Cardiomyocyte death in doxorubicin-induced cardiotoxicity
Doxorubicin (DOX) is one of the most widely used and successful antitumor drugs, but its
cumulative and dose-dependent cardiac toxicity has been a major concern of oncologists in …
cumulative and dose-dependent cardiac toxicity has been a major concern of oncologists in …